STABILIZED INTEFERON COMPOSITIONS

Stabilized pharmaceutical formulations comprising IFN- beta and highly purified mannitol are provided. The highly purified mannitol stabilizes the compositions by reducing the formation of IFN- beta adducts in comparison with IFN- beta formulated with mannitol that has not been highly purified. Meth...

Full description

Saved in:
Bibliographic Details
Main Authors HORA, MANINDER, S, WOLFE, SIDNEY, N
Format Patent
LanguageEnglish
French
Published 27.03.2003
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Stabilized pharmaceutical formulations comprising IFN- beta and highly purified mannitol are provided. The highly purified mannitol stabilizes the compositions by reducing the formation of IFN- beta adducts in comparison with IFN- beta formulated with mannitol that has not been highly purified. Methods for increasing the stability of IFN- beta or a variant thereof in a liquid or lyophilized composition and for increasing storage stability of such a composition are also provided. L'invention concerne des préparations pharmaceutiques stabilisées P comprenant IFN- beta et du mannitol fortement purifié. Le mannitol fortement purifié stabilise les préparations en réduisant la formation de produits d'additions IFN- beta par comparaison avec IFN- beta formulé avec le mannitol qui n'a pas été fortement purifié. L'invention concerne également des procédés d'augmentation de la stabilité de IFN- beta ou d'un variant de celui-ci dans une préparation liquide ou lyophilisée et pour accroître la stabilité de stockage de cette préparation.
Bibliography:Application Number: WO2001US47514